National Institute of Allergy and Infectious Diseases (NIAID)
Bethesda, Maryland, 20892, United States
NCT Number: NCT00001904
This minimal risk protocol is designed to assess the reproducibility of B-mode ultrasound measurements of carotid intima media thickness (IMT) when the scans are performed in CC Radiology and read using a computerized edge reader. Up to 20 volunteers will have two ultrasounds performed within a 6-month period. IMT thickness is used as a surrogate marker for atherosclerosis and may be of value in clinical trials.
Looking for future studies?
Notify MeAll sexes
Observational
Bethesda, Maryland, 20892, United States
This minimal risk protocol is designed to assess the reproducibility of B-mode ultrasound measurements of carotid intima-media thickness (IMT) when the scans are performed in CC Radiology and read using a computerized edge reader. Up to 50 volunteers will have two ultrasounds performed within a 6-month period. IMT thickness is used as a surrogate marker for atherosclerosis and may be of value in clinical trials.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Adult (age 18 or older).
Desire to participate in the study; willing and able to provide informed consent.
No history of stroke or carotid disease.
National Institute of Allergy and Infectious Diseases (NIAID)
Nih
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00005143
Arterial Occlusive Diseases, Arteriosclerosis
View Trial DetailsNCT00272337
Arterial Occlusive Diseases, Arteriosclerosis
Atlantis, Florida, United States
View Trial DetailsNCT00880178
Arterial Occlusive Diseases, Arteriosclerosis
Birmingham, Alabama, United States
View Trial DetailsNCT00031200
Arterial Occlusive Diseases, Arteriosclerosis
View Trial Details